SkinBioTherapeutics (LSE:SBTX) FFO


LSE:SBTX SkinBioTherapeutics PLC LSE:SBTX
40 GF Score
Price £0.12
GF Value £0.64
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is SkinBioTherapeutics FFO?

FFO (Funds from operations) only applies to REITs.

LSE:SBTX
40GF Score
SkinBioTherapeutics PLC LSE:SBTX
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is SkinBioTherapeutics (LSE:SBTX) Overvalued in 2026?

Based on GuruFocus' analysis, SkinBioTherapeutics stock appears to be undervalued. The current stock price of £0.12 is trading 80.9% below its estimated GF Value™ of £0.64. GuruFocus considers SkinBioTherapeutics to be Possible Value Trap.

Key valuation signals for LSE:SBTX:

  • FFO:
  • GF Value™: £0.64 vs. price of £0.12 (80.9% below fair value)
  • GF Score™: 40/100 with 3 warning signs

No single metric tells the full story. See the LSE:SBTX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


SkinBioTherapeutics Business Description

Address Bath Lane, The Core, Newcastle Helix, Newcastle upon Tyne, GBR, NE4 5TF
SkinBioTherapeutics PLC is a life science company focused on skin health. It is focused on the development of technology to protect, manage, and restore skin utilizing proteins found in the human microbiota. It is targeting three specific skin healthcare sectors; cosmetics, infection control, and eczema.
40GF Score

Get the complete analysis for LSE:SBTX

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£0.12
Price
£0.64
GF Value